- About CSAM
- Public Policy
Physicians dedicated to improving the treatment of substance use disorders. A State chapter of the American Society of Addiction Medicine.
Addiction Medicine Review Course and ABAM Certification Exam Preparation Track
August 24-27, 2016 | Anaheim Marriott • Anaheim, California
Registration opens in January 2016. Check back for more information and to register.
2014 Review Course and ABAM Certification Exam Preparation Track are available online
What people are saying about the 2014 Review Course:
- “Absolutely outstanding in terms of material presented. Found the conference stimulating, motivating and thought provoking. I feel the energy to change and educate the world about this epidemic of addiction that affects all of us.”
- “One of the best conferences ever attended; well organized, excellent and knowledgeable presenters, and friendly staff. It helped me to prepare for the exam and now I feel more confident to take the test.”
CSAM Cannabis Policy Statements
An initiative to legalize cannabis is highly likely to appear on the 2016 California ballot. In the advent of policy changes that may increase availability of cannabis, an addictive drug, what are credible and evidenced-based positions that prevent addiction, prevent harm to vulnerable populations, and promote access to quality treatment? CSAM believes that it is not necessary to support an initiative to work toward ensuring that whatever initiative is presented or eventually adopted takes measures to mitigate public health harms associated with expanded access to and use of cannabis.
- CSAM has established recommendations for cannabis policy in the prospect of possible ballot initiatives legalizing cannabis in California. [Read CSAM recommendations]
- The Adult Use of Marijuana Act (Initiative No. 15-0103) is one of several initiatives that are seeking a place on the 2016 ballot. CSAM has submitted comments to the initiative's drafters through to the California Attorney General's Office. [Read CSAM comments]
Minimum Insurance Benefits for Medically-Assisted Treatment of Opioid Dependence
CSAM’s Consumer Guide and Scorecard rating Covered California health plans on coverage for addiction treatment, published last year disclosed that not a single health plan offered the minimum health insurance coverage for medically-assisted treatment of opioid dependence. In most plans physicians were not allowed to choose the appropriate medication, with plans offering either methadone OR buprenorphine. Many plans also required physicians to provide extensive paperwork every month for on-going treatment. CSAM’s Committee on opioids will be advocating that ALL insurance plans meet these standards by meeting with insurance regulators and insurance companies. As part of this Committee members Tauheed Zaman, MD and Joan Striebel, MD drafted a report that describes the minimum benefits insurance companies should provide to meet standards of evidence-based practice.